Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lysozyme
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Monitor CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 13, 2017
Lead Product(s) : Lysozyme
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Monitor CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lysozyme
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 29, 2012
Lead Product(s) : Lysozyme
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable